Harpoon Therapeutics, Inc.
Records under this name other than the patents Harpoon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
Showing 1 to 5 of 5 · Back to Harpoon Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,208,285 | Compositions and Methods for TCR Reprogramming Using Fusion Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 11,085,021 | Compositions and Methods for TCR Reprogramming Using Fusion Proteins Formerly held Lapsed on the fee record Ended Aug 10, 2025 · High confidence | Lapsed on the fee record | Ended Aug 10, 2025 | High confidence |
| US 10,849,973 | Prostate specific membrane antigen binding protein Lapsed on the fee record Ended Dec 1, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 1, 2024 | USPTO record |
| US 10,844,134 | PSMA targeting trispecific proteins and methods of use Lapsed on the fee record Ended Nov 24, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 24, 2024 | USPTO record |
| US 10,730,954 | MSLN targeting trispecific proteins and methods of use Lapsed on the fee record Ended Aug 4, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 4, 2024 | USPTO record |